In a modest office building at 100 Ryan Street, an Indian botanical company is rolling out a product strategy it believes can reset how supplement formulators think about herbs.
Greenspace Herbs, based in Bengaluru, has opened a full-fledged US office with a dedicated US team to commercialize what it calls ‘Quantum Ayurveda’ (QA) – a line of energized ingredients and polyherbal blends that the company says act faster and at lower doses than conventional extracts.
The idea is unapologetically ambitious. Curcumin, ashwagandha and berberine are already staples across the dietary supplement space. Greenspaces proposition is not a new herb, but a new version of known actives: five ‘QA’ products it describes as the world’s first energized Ayurvedic ingredients and poly blends, all formally launched at SupplySide Global 2025 in Las Vegas.
Executives privately use a striking metaphor to explain the difference. Standard botanical extracts, they say, are like reliable family sedans. The QA versions are ‘Formula 1 racing car ingredients’ – tuned, stripped of friction and designed to move faster through the body’s biological track.
Five products, one thesis
The initial portfolio is deliberately tight. On the single-ingredient side, Greenspace is offering:
- Curcumin QA Built on turmeric’s flagship compound and positioned for joint, inflammatory and overall resilience formulas
- Ashwagandha QA Targeting stress, sleep and performance categories
- Berberine QA Aimed at metabolic health, blood sugar and weight-management products
Complementing those are two polyherbal blends:
- Femheal QA Focused on women’s health, cyclical comfort and hormonal balance
- NerviTheraQA Designed for endurance, nervous-system support and high-output lifestyles
All five share the same underlying thesis: herbs do not just deliver chemistry; they also carry energy. Greenspace Herbs’ claim is that by ‘loading’ the raw materials with what it describes as human-body-friendly energies, it can remove subtle hurdles that can slow the onset of benefits.
The company asserts that QA ingredients are able to deliver equivalent or better effects at lower doses, with a noticeably faster time to perceived impact. For formulators, that translates into the possibility of smaller capsules, simpler stacks and fewer pills per day, particularly attractive in crowded categories like stress, joint health and blood sugar support.
A Las Vegas debut
SupplySide Global 2025 served as the public proving ground. On the trade show floor, Greenspace Herbs ran side-by-side demonstrations comparing conventional extracts with QA versions. Chemistry, the company says, remained unchanged. The difference lay in the energetic profile, produced via a proprietary quantum energy-loading process conducted in small batches.
While those energy signatures are invisible to consumers, Greenspace Herbs says they are measurable in the lab and meaningful in the body. The company reported brisk interest from North American and European brands for white-label formulations and custom products built around the QA ingredients.
The five Stock Keeping Units (SKUs) are designed to slot easily into existing product lines. Curcumin QA and Berberine QA can substitute directly for standard extracts in joint or metabolic formulas. Ashwagandha QA targets the booming ‘calm and focus’ segment. Femheal QA and NerviTheraQA give brands turnkey stories in women’s health and endurance, two of the fastest-growing supplement niches.
Clinically studied speed and dose
In a market flooded with ‘next generation’ claims, hard data is a differentiator. Greenspace Herbs says it has run clinical and preclinical work explicitly designed to quantify two variables: speed to effect and dose efficiency.
According to company executives, early human studies indicate that the QA versions of key ingredients can reach meaningful endpoints faster than comparable standard extracts, while requiring less material to achieve similar or superior results. The company highlights outcomes such as quicker perceived relief, improved time-to-first-effect metrics and the ability to design formulas around reduced daily milligram counts.
The full datasets have not yet been broadly released, and Greenspace is in the process of pursuing peer-reviewed publication and additional trials in both India and the US. Until then, the clinical story remains a developing asset. But for brand owners under pressure to justify premium pricing and differentiate beyond flavor and dosage form, the prospect of faster, lower-dose actives is a compelling talking point.
Small-batch physics meets scaling pressures
The technological heart of the QA line is also its current bottleneck. Greenspace Herbs quantum energy-loading process is an inherently small batch. Ingredients are exposed to tightly controlled energy fields inside shielded chambers, with each run monitored and validated against both chemical and energetic specifications.
That structure offers a degree of control and narrative appeal, but it complicates scale. Since the SupplySide Global launch, the company has seen rising inquiries for Curcumin QA, Ashwagandha QA and Berberine QA as drop-in upgrades for existing product lines, as well as for Femheal QA and NerviTheraQA as flagship SKUs. Meeting that demand without diluting the process is a core operational challenge.
To address it, Greenspace Herbs is investing in what it describes as world-scale quantum lab expansion, anchored in India and ultimately mirrored in other geographies. The build-out includes additional loading suites, upgraded analytics and AI-supported quality systems that track not just purity and potency, but the stability of the energetic imprint through manufacturing, transport and shelf life.
A product-led entry into the US
The South Plainfield office is designed to be more than a sales address. From New Jersey, Greenspace Herbs’ team will work with American and Latin American brands on formulation design, regulatory strategy and clinical partnerships built around the five QA products.
The approach is deliberately product-led. Rather than leading with a platform story and leaving customers to interpret it, the company is putting named SKUs front and center: Curcumin QA for joints and resilience, Ashwagandha QA for stress and sleep, Berberine QA for metabolism, Femheal QA for women’s health, NerviTheraQA for endurance and nerve support.
Behind them sits a broader conviction that could resonate well beyond one trade show cycle. If, as the company’s leadership often notes, everything is energy before it is matter, then supplements will eventually be judged not only on what they contain, but on how their ingredients are energetically prepared.
Whether that view becomes mainstream or remains a specialty lane is uncertain. What is clear is that Greenspace Herbs has staked out an early, product-focused position in a category it is effectively naming as it goes. For an industry where differentiation is increasingly hard to find, five energized SKUs with a Formula 1 story may prove to be a starting grid worth watching.
